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Abstract  
Patient and public involvement (PPI) is a process whereby patients, care givers, service users, and other 
relevant stakeholders, including the general public,  are actively involved and engaged in activities to 
develop research. The dental research agenda has traditionally been driven by clinicians, where patients 
and the public have participated in research as subjects; patient and public involvement can contribute to 
the research agenda including the design and conduct of research by providing unique perspectives gained 
through lived experience.. This panel of the 8th World Workshop on Oral Health and Diseases in AIDS 
considered the role of people living with (PLHIV) to contribute to oral health and HIV research and policy 
through a process of involvement and empowerment.  The panel introduced the concepts of PPI, 
described the purpose of PPI, reflected upon the logistic and ethical considerations thereof and 
considered how PPI had been utilised effectively in HIV research and policy change. The audience 
discussion focused on ways in which PPI could more readily and consistently be encouraged within oral 
health research involving PLHIV.   
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Introduction 
The dental research agenda has traditionally been driven by clinicians, where patients and the public have 
only participated in research as subjects. In recent years however, the research paradigm in healthcare 
has been shifting toward the inclusion of patients and the public in the development and conduct of 
research; this is particularly evident in the field of HIV research where advocates for people living with 
HIV (PLHIV) have been recognised as an asset in the HIV/AIDS response for more than two decades 
(UNAIDS, 1999).  
 There is growing recognition that working with (rather than on) communities to study and address their 
issues and concerns can have a greater influence on policy and promote health equity. Involving patients 
and the public in research and policy development has increasingly become a priority for policymakers, 
commissioners, funding bodies, researchers and also patients (“CEPPP, 2017; Hanney et al., 2010; Walshe 
et al., 2013).  
Increasingly patient and public involvement (PPI) is becoming a requirement of research funding bodies; 
therefore, an understanding of the concepts of PPI will become ever more important to the dental 
researcher.   
Within the context of this workshop at the 8th World Workshop on Oral Health and Diseases in 
AIDS, the panel members considered the role of PLHIV to contribute to oral health and HIV research and 
policy through a process of involvement and empowerment.  The panel introduced the concepts of PPI, 
described the purpose of PPI, reflected upon the logistical and ethical considerations thereof and 
considered how PPI had been utilised effectively in HIV research and policy change. The audience 
discussion focused on ways in which PPI could more readily and consistently be encouraged within oral 
health research involving PLHIV.   
 
What do we mean by PPI in research and what is the purpose of PPI in research?   
PPI is a process whereby patients, care givers, service users, and other relevant stakeholders (or the 
public)  are actively involved and engaged in activities to develop research; research is undertaken with 
or by the public and not to, about or for them (INVOLVE, 2018). Within this manuscript, the term PPI will 
be used to cover all activities that involve patients and the public in research, though the panel 
acknowledges that other terms may be in common use e.g. engagement, co-design, co-implementation, 
co-production, participation and others.  While, engagement and participation are important ways of 
interacting with people in research, involvement provides a very influential and meaningful insight that is 
essential to anyone aspiring to improve the quality of life of patients (ARTHRITIS UK, 2018). 
Involving patients and the public in the research process recognizes people and their lived experiences as 
assets rather than deficits; the approach promotes reciprocity and mutual respect and recognises the 
value of including the experience-based perspectives of the public alongside clinical and scientific 
approaches (INVOLVE, 2012) (Cartwright & Crowe, 2011). Patients and public members are involved as 
equal partners.   
There are numerous examples of PPI in health and social care research, including developing good practice 
guidelines for health technologies, clinical practice and public health, prioritising research ideas, reviewing 
research funding proposals, contributing to research bids, design, analysis, and dissemination, designing 
patient information sheets and advising on recruitment (Oliver, Armes, and Gyte,  2006; Ross et al. 2005;  
Koops & Lindley, 2002).  
 For PPI to be effective, six salient actions are required to promote a clear purpose, role and structure for 
PPI (includes a key individual coordinating PPI); ensuring diversity; whole research team engagement with 
PPI; mutual understanding and trust between the researchers and lay representatives; ensuring 
opportunities for PPI throughout the research process; and PPI being appraised and evaluated using a 
systematic approach (Wilson et al., 2015).  
The Joint United Nations Programme on HIV/AIDS (UNAIDS) Greater Involvement of PLHIV (GIPA) policy 
recognises that PLHIV have a right to self-determination and participation in the decision-making process 
(UNAIDS, 2007). Moreover, GIPA provide numerous examples of activities with which PLHIV can be 
involved which have relevance for researchers; these could include public speaking, campaigns, advocacy, 
encouraging participation of new participants, development and implementation, treatment roll-out and 
preparedness and policy-making processes.  
What is the purpose of PPI in Research?  
There are three prevailing arguments for the key purposes and benefits of PPI: 1) PPI addresses the power 
imbalance between patients and researchers 2) Lived experiences can improve both the efficiency and 
value of research by increasing its relevance, improving recruitment and retention rates and supporting 
dissemination to target populations 3) Increased accountability and transparency of research through the 
alliance built between researchers and patients  (Greenhalgh et al., 2019) . Crocker et al. (2017) described 
various impactful roles of PPI, who could be conceptualized as the 'expert in lived experience', the 
'creative outsider', the 'free challenger', the 'bridger', and the 'motivator'.  
Researchers affirm that PPI will enhance the quality of the research due to influences on, for example, the 
identification of appropriate research priorities, and research design. Additionally, PPI will help ensure 
that the design of the research is relevant, that it is participant friendly and safe, sensitive and ethically 
sound (Brett et al., 2014; South et al., 2016). This will in turn ensure that research is relevant to user needs 
and hence more likely to have beneficial impacts. Furthermore, there is evidence to suggest that the 
public, as citizens and taxpayers, has a democratic right to influence research that is publicly funded or 
advanced in the name of the public good (Thompson et al., 2009).  
 Moreover, to the individual PLHIV participation can also have personal benefits including improved self-
esteem, decreased isolation and depression and resultant improvements in health through better access 
to information (UNAIDS, 2007). Similarly, it has been reported that  PPI provides a framework for sense 
making in which participants are able to exhibit a degree of agency through their choice to participate in 
these roles, to develop research knowledge and skills, and to re-establish (or maintain) the professional 
self (Thompson et al., 2014).  
PPI can act at several points in the journey of a research project, from the conception of the research 
question through recruitment, treatment and outcomes to the analysis and interpretation of results 
(Needleman, 2014).  However, it is important to ensure that PPI is not adopted as a token gesture rather 
than a more meaningful and active contribution to the research process. 
 
How do people living with HIV contribute to research, policy and practice?  
Greater Involvement of PLWH (GIPA) 
GIPA is not a project or program. It is a principle that ensures the rights and responsibilities of PLHIV, 
including their rights to self-determination and participation in decision-making processes that affect their 
lives. Since the start of the HIV pandemic, community responses have been sparked and propelled by 
social movements led by PLHIV and most affected populations, including people who inject drugs (PWID), 
men who have sex with other men (MSM), transgender people, and sex workers. Their movement and 
actions have become critical to shaping the global health agenda, including global political commitments 
to ensure the fulfillment of the rights of PLHIV (UNAIDS, 2007). 
 The idea that personal experiences should shape the AIDS response was first voiced by PLHIV in June of 
1983, at the Fifth Annual Gay and Lesbian Health Conference in Denver (The Denver Principles, 1983). It 
was for the first time that AIDS activism started to become more collective for a common goal – that PLHIV 
voices were heard and PLHIV expertise, as individuals living with the disease, was respected. A manifesto 
known as the Denver Principles states the following:  
“We condemn attempts to label us as “victims,” a term which implies defeat, and we are only occasionally 
“patients,” a term which implies passivity, helplessness, and dependence upon the care of others. We are 
“People with AIDS.”  
The Denver Principles were the foundation of GIPA, which was formalised in 1994 through the Paris 
Declaration (The Paris Declaration, 1994). In 2001, 189 United Nations Member States endorsed the GIPA 
Principle as part of the Declaration of Commitment on HIV/AIDS (UNAIDS, 2001)  
 
The Benefits of GIPA 
Many reasons have been cited for involving PLHIV, including more tailored and responsive programs and 
policies. This is important because responses must address the diverse needs and issues faced by PLHIV 
and key affected populations. This autonomous approach allows people to make decisions that affect 
their lives.   
  
From Principles to Practice 
Ways of practicing GIPA 
There are many ways of practicing GIPA, such as greater involvement in the choice, design, 
implementation, monitoring and evaluation of programmes and research; increased participation in 
advocacy such that PLHIV can advocate for law reform, inclusion in the research agenda, increased access 
to services and resource mobilization. There has been a drive to work with organisations of PLHIV as these 
organisations are vital and credible partners in the HIV responses.  
GIPA has been integrated at different stages: 
1) Assessment: where PPI helps to focus on the issues that are most important and relevant to the 
affected community.  
2) Planning and design: where PPI increases the likelihood that the research project will meet the 
needs of the target audience, and help to reduce the stigmatization of PLHIV in the community  
3) Implementation: where PPI enhances the likelihood that the approaches will be non-judgmental 
and appropriate  
4) Monitoring and evaluation which helps to ensure that the most relevant matters to the 
community of PLHIV are being explored.  
What are the logistical and ethical considerations for patient and public involvement? 
One of the main responsibilities of a research ethics committee is to protect potential participants and 
also take into account the potential risks and benefits  for the community in the research will be carried 
out. However, this has been criticised as often comprising too narrow a view of citizens with the reality 
that those involved generally are retired, white, middle-class, and highly educated (Martin, 2007). An 
alternative viewpoint is the ethical argument that all individuals have a right to be fully involved in any 
research intervention being done ‘to’ them as a person. Patient public involvement recognises the 
importance of experiential knowledge of a diverse community.  
The involvement of patients has taken different approaches including: 
1) A paternalistic model which assumes professionals know best and therefore patients must trust 
in skills of experts.  
2) A consumerist model which assumes that individuals are in charge of getting the ‘best buy’; an 
autonomy model which places respect for the individual first  
3) A partnership model which views the giving and receiving of healthcare and related services as a 
negotiation (Gradinger et al., 2015).  
All of these models are likely to be evident in the ways in which health and social care regulators work 
and how individuals in those organisations think about patient and PPI. In general, researchers 
internationally may still adopt, by virtue of habit or familiarity, the increasingly outdated paternalistic 
model; however, in the United Kingdom the partnership model resonates with current thinking on PPI.  
Research exploring values associated with public involvement in health and social care research identified 
three broad value systems: firstly, a value system focused on moral, ethical and/or political concerns;  
secondly, a value system focused on concerns about the consequences of public involvement in research 
and thirdly a value system focused on concerns about the conduct of patient involvement (Gradinger et 
al., 2015).  
A pragmatic approach to PPI requires considered thought, preparation, time and money. However, there 
could be an expectation of better outcomes as this captures the “lived in” narrative. The process of PPI 
may highlight learning needs both for the group and the organization, thereby requiring responsiveness 
and flexibility to adapt to the needs of the different individuals. Therefore, a context-specific framework 
is proposed to avoid PPI tokenism and to make the process meaningful. Frameworks describe key points 
of involvement spanning from early and regular involvement which allows input prior to trial 
implementation (e.g. in contributions to grant writing, trial design) through to active engagement as 
research partners (Domecq et al., 2014).  
Examples of good practice in PPI can be found globally at different levels within different structures. In 
India, The National AIDS Control Organisation (NACO) of India has a PLHIV on its research proposal ethics 
committee (NACO, 2006). In South Africa, there are various forums through which engagement with 
patients, communities, civil society organisations and other stakeholders takes place, not only for research 
but also for development of policy. The South African National AIDS Council (SANAC), chaired by the 
Deputy President ensures a robust response against HIV, tuberculosis (TB) and sexually transmitted 
infections (STIs) and focuses on building a collective and coherent approach between Government, Civil 
Society and Business (SANAC, 2008).  
 The active engagement of patients as research partners is increasingly viewed as essential to ensuring 
that the patient perspective is considered throughout the research and healthcare process and the 
following section will describe ways in which PPI could become the status quo for dental researchers 
beyond the World Workshop.  
How can we integrate Patient and Public Involvement into research beyond WW8? 
Patients have a right to articulate the unmet needs that affect their lives. Therefore, it is plausible to 
involve patients and the public in research at every level from the beginning at the stage of conception of 
ideas, right through to implementation and dissemination of results (STIGMAINDEX, 2008).  Equal 
partnership in setting the research agenda and prioritizing research areas builds ownership of issues and 
solutions between researchers and patients. This shifts the narrative from a conventional form of research 
being done on them to conducting research with them. This is an empowering process of engagement for 
both researchers and communities that leads to an empowered community who take control of their lives 
and who feel engaged.  
PLHIV have been instrumental in designing, implementing, and contributing to evidence-based 
programming and research within the HIV field.  This is well documented and published widely in many 
platforms including International AIDS Conferences held biannually, scientific conferences and peer-
reviewed journals. Many national and international institutions including the National Institutes of Health 
(NIH) and Centers for Disease Control and Prevention (United States) and the National Health Service 
(United Kingdom) have collaborated with PLHIV groups and networks in determining research priorities. 
This  has set precedence for the World Workshop  which could provide yet another space for the 
researchers and patients to continue this  dialogue around research priorities on oral health for PLHIV and 
other key populations affected by HIV and AIDS. 
UNAIDS along with its co-sponsors and global networks like The Global Network of PLHIV (GNP+) and the 
International Community of Women Living with HIV (ICW) have developed the PLHIV Stigma Index tool,  a 
quantitative survey that helps to measure stigma and discrimination faced by PLHIV and key populations 
living with HIV (STIGMAINDEX, 2008).   Patient groups were involved in its development from the 
beginning and the implementation of the tool at national level was rolled out by the PLHIV networks 
themselves. The outcomes of such efforts have led to scaling up of peer led participatory research 
initiatives in many countries across the world. The WHO in 2016-17 supported regional and global 
networks of the Salamander Trust and ICW to develop a global survey on values and preferences of 
Women Living with HIV (Narasimhan et al., 2016). The findings from that survey were reviewed and 
integrated in reviewing WHO’s global guidelines on Sexual and Reproductive Health and Rights (SRHR) for 
Women living with HIV.  This practice has been welcomed by WHO and UN cosponsors and recommended 
for formalization within the WHO research unit (WHO, 2019). 
 The WW8 conference has highlighted initiatives which have integrated PPI into research at different 
levels globally. National governments and research institutes in public health/communicable diseases and 
non-communicable diseases have revised their guidelines to involve patients and public in processes 
related to research-such as the Community Advisory Board (CAB) and on ethics committees.  Further 
schemes have integrated patient groups in identifying research priorities/research setting agenda at 
national level, sub-regional and local level.  
Discussion   
The discussion following the PPI panel presentation centered around the ways in which PPI could be 
supported within the field of oral health and HIV research. The solutions for the integration were 
described at various levels: research project support through toolkits, checklists and protocols, presence 
of lay persons on research ethics committees and an ethical imperative of committees to require 
researchers’ PPI strategies at an early stage; additionally lay research committee panels could review 
research proposals prior to application to funder to develop and refine concepts at an early stage.  These 
points will be discussed in turn and illustrated with existing examples implemented at national and 
institutional level across the globe. Where possible, these examples pertain specifically to the involvement 
of PLHIV.  
Local ethics committees and review boards 
At a local level in South Africa, CABs provide input for research and co-creation and can support activities 
such as patient recruitment, demand creation, patient flow, user experience (SANAC, 2008). Researchers 
present to CAB at an early stage and then periodically thereafter.  Furthermore, the Indian Council of 
Medical Research ethical guidelines recommends patient/community representations are involved in 
institutional review boards or Institutional Ethics Committees (Mathur & Swaminathan, 2018). Similar 
mechanisms could be implemented within dental institutes to encourage researchers to include PPI in 
their proposals and to support them to do so. Having access to CAB support enables researchers to better 
consider where PPI might be included in their study at an early stage in the development of the proposal.  
Toolkits, checklists and protocols 
PPI protocols or toolkits can help to support the researcher across three domains: 1) identification of the 
purpose of research and most appropriate outcomes to demonstrate this; 2) understanding the best 
approaches to involving patients and the public in research; 3) clarification of what the researchers and 
the patients and public involved in the research can expect from one another; more specifically, how the 
voices of PPI contributors will shape the research (Cartwright & Crowe, 2011).   
While PPI may have been used in the development of dental research, it is not often described in the 
traditional structure of published manuscripts. Therefore, the dental researcher may wish to utilise tools 
such as guidance for reporting of PPI in health and social care research (Staniszewska et al., 2017). Utilising 
a toolkit supports standardisation and transparency in the reporting methods, thereby strengthening the 
quality of the international PPI evidence base. 
National level organisations in the United Kingdom exist to support researchers to integrate PPI. 
Organisations such as Involve provide online resources including toolkits and hold libraries of PPI 
evidence. In Canada the Centre of Excellence on Partnership with Patients and the Public (CEPPP) has a 
similar repository of tools to augment the PPI armamentarium (CEPPP, 2015).  
Lay research committee panels  
More specific to involving PLHIV in research, the British Association for Sexual Health and HIV in 
conjunction with Terrence Higgins Trust, founded in 1982, offer a lay research panel to researchers for 
review of their research proposals at early stages before submission for research funding (Terrence 
Higgins Trust, 1982). Such committees support the rigorous review of research application by patients 
and the public before the research funding is obtained, in this way, the researchers ensure that not only 
is the research question important to the target population, but moreover, that PPI will be adequately 
funded and utilised most effectively throughout the project. 
As PPI is still relatively novel within the oral health and HIV research domain, there exists a plethora of 
ways in which it could be integrated and supported by a growing body of evidence and tools developed 
by the wider health and social science research spheres; the panel are hopefully that interest in PPI will 
continue beyond WW8 and into the research practices in oral health and HIV.   
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